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1098Objective: Our objective was to define the relationship between surgical technical performance score, intrao-
perative adverse events, and major postoperative adverse events in complex pediatric cardiac repairs.
Method: Infants younger than 6 months were prospectively followed up until discharge from the hospital. Tech-
nical performance scores were graded as optimal, adequate, or inadequate based on discharge echocardiograms
and need for reintervention after initial surgery. Case complexity was determined by Risk Adjustment in Con-
genital Heart Surgery (RACHS-1) category, and preoperative illness severity was assessed by Pediatric Risk of
Mortality (PRISM) III score. Intraoperative adverse events were prospectively monitored. Outcomes were an-
alyzed using nonparametric methods and a logistic regression model.
Results: A total of 166 patients (RACHS 4-6 [49%]), neonates [50%]) were observed. Sixty-one (37%) had at
least 1 intraoperative adverse event, and 47 (28.3%) had at least 1 major postoperative adverse event. There was
no correlation between intraoperative adverse events and RACHS, preoperative PRISM III, technical perfor-
mance score, or postoperative adverse events on multivariate analysis. For the entire cohort, better technical per-
formance score resulted in lower postoperative adverse events, lower postoperative PRISM, and lower length of
stay and ventilation time (P<.001). Patients requiring intraoperative revisions fared as well as patients without,
provided the technical score was at least adequate.
Conclusions: In neonatal and infant open heart repairs, technical performance score is one of themain predictors
of postoperative morbidity. Outcomes are not affected by intraoperative adverse events, including surgical revi-
sions, provided technical performance score is at least adequate. (J Thorac Cardiovasc Surg 2011;142:1098-107)Supplemental material is available online.Outcomes after repair of complex congenital cardiac
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The Journal of Thoracic and Cardiovascular SurIt is also widely known that outcomes, both immediate
and long-term, after complex cardiac repairs in neonates
and infants are dependent on multiple and interrelated fac-
tors such as case complexity, preoperative physiologic sta-
tus (‘‘severity of illness’’), conduct of operation (including
intraoperative anesthetic management, CPB, intraoperative
adverse events, and surgical technique), volume of cases at
a given institution, and postoperative management, includ-
ing the occurrence of postoperative major adverse events.1-4
Previous studies have looked at these factors in isolation
or have studied a single diagnostic group or operation1-4 in
both a retrospective and a prospective fashion. Other studies
have looked at the impact of human factors on outcomes
and concluded that human factors have an important role
to play, although hidden and harder to measure, in
outcomes after cardiac surgery.3,5 Previous retrospective
work at our institution has focused on technical
performance and established that technical performance,
as measured by a technical score specific to each
operation, is one of the major contributors to outcomes.1,4
We also found that optimal technical performance could
neutralize the detrimental effects of poor preoperative
physiology or case complexity.
The aim of this study is to prospectively define the role
and relationship of each of these factors in a group ofgery c November 2011
FIGURE 1. ROC curve analysis of ability of technical performance,
RACHS-1 categories, and preoperative PRISM to predict major postop-
erative adverse events. On logistic regression, technical performance
had a higher (albeit small difference) significance in predicting occur-
rence of postoperative adverse events with an area under the curve of
0.774 (95% CI, 0.681-0.867) versus 0.756 (95% CI, 0.681-0.832) for
RACHS-1 category versus 0.732 (95% CI, 0.650-0.814). ROC, Re-
ceiver operator characteristic; RACHS, Risk Adjustment in Congenital
Heart Surgery; PRISM, Pediatric Risk of Mortality; CI, confidence
interval.
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
ICU ¼ intensive care unit
PRISM ¼ Pediatric Risk of Mortality
RACHS ¼ Risk Adjustment in Congenital Heart
Surgery
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diac repairs. Our hypothesis was that technical performance
would be the most important determinant of outcomes and
that technical performance would attenuate the effects of
case complexity and preoperative physiologic status and
neutralize the deleterious effects of intraoperative adverse
events.
PATIENTS AND METHODS
Institutional review board approval was obtained for conduct of this
study. Data were collected prospectively. Patients were observed intraoper-
atively from induction of anesthesia to transfer to the intensive care unit,
and their postoperative course was followed prospectively until discharge.
Data Collection
Intraoperative observations of infants less than 6 months of age and Risk
Adjustment in Congenital Heart Surgery (RACHS) categories 2 to 6 were
performed from October 2008 to April 2010. All observations were per-
formed by fully trained pediatric cardiac surgeons. All adverse events (mi-
nor or major) related to conduct of anesthesia, the operative procedure,
CPB, and events related to communication were documented. Patients of
6 surgeons (experience levels in years of practice after completion of pedi-
atric cardiac surgery training: 1 year, 5 years, 11 years, 11years, 20 years,
and 25 years) were prospectively followed up from intraoperative observa-
tion until discharge from the hospital. Clinical data including physiologic
status measurements (vital signs), laboratory tests, echocardiograms, and
cardiac catheterization data were collected. Variables collected for analysis
included age, weight, prematurity, presence of extracardiac and genetic ab-
normalities, case complexity and technical performance scores, preopera-
tive and postoperative Pediatric Risk of Mortality (PRISM) III scores, and
preoperative and postoperative lactate. The following time variables were
also collected: CPB times, crossclamp times, deep hypothermic circulatory
arrest and regional perfusion times (where applicable), postoperative and
total intensive care unit (ICU) and hospital length of stay, and postoperative
ventilation days. Need for intraoperative surgical reintervention or postop-
erative surgical or catheter-based reinterventions were documented.
Predictor Variables
The main predictor variables that were included in our analysis were
case complexity, physiologic status, and technical performance.
Case complexity was scored on the basis of the RACHS-1 scoring
system.6,7
The preoperative and postoperative physiologic status was determined
using the PRISM III scoring system8 and lactate levels. For the PRISM
III score, 17 physiologic variables were used. Data were collected in the
24 hours before surgery and for 48 hours after surgery. In infants who
did not have preoperative arterial blood gas measured, an empiric score
of 6 was given for all cyanotic lesions based on a presumed arterial oxygen
tension of 40 mmHg, and a presumptive value of 1 was assigned for lactate
level. The highest lactate level in each 24-hour time period was used for
scoring lactate levels.The Journal of Thoracic and CarTechnical performance was scored as previously reported from
our center,9,10 based on intraoperative course, predischarge
echocardiogram, catheterization data, and clinical status at discharge.
In brief, each operative procedure was divided into subcategories and
each subcategory was assigned an optimal, adequate, or inadequate
score based on specific echocardiographic and in some instances
catheterization and clinical criteria. Any intraoperative reinterventions
resulted in the score being downgraded to adequate, even if the final
score was ‘‘optimal.’’ Any postoperative surgical/catheter-based reinter-
ventions for residual defects resulted in an inadequate score. At dis-
charge, echo and clinical status were reviewed, and for the procedure
of interest, if all subcategories were optimal, then the final score was op-
timal; however, if one of the subcategories had an adequate score, it was
scored as adequate. If any subcategory was scored as inadequate, then the
final score was inadequate. Technical scores were thus graded as ‘‘opti-
mal,’’ ‘‘adequate,’’ or ‘‘inadequate’’ for each patient for the index
operation.
Outcome Variables
The outcome variables that were analyzed were the following:
 Primary: Occurrence of major postoperative adverse events
 Secondary: ventilation time, ICU length of stay, and hospital length of
staydiovascular Surgery c Volume 142, Number 5 1099
TABLE 1. Intraoperative surgical reintervention (n ¼ 12; 7%)
No. RACHS Diagnosis Intraoperative reintervention Final technical score Outcome
1 RACHS 2 Multiple VSDs Closure of residual and unidentified VSD 2 DC
2 VSD, RVOTO Further RVOT resection 2 DC
3 RACHS 3 TOF/APV Revision of RPA anastomosis 2 DC
4 CAVC Repair of right AVV 2 DC
5 CAVC Revision of VSD patch for AVVR 2 DC
6 TGA/IVS Revision of PA anastomosis for supra systemic RV pressures 2 DC
7 TOF/CAVC Further closure of LAVV cleft and further restriction of ASD 2 DC
8 RACHS 4 TGA/VSD Plication of LPA to move away from left coronary button 2 DC
9 TOF/MAPCAs Fenestration of VSD 3 DC
10 RACHS 6 Unbalanced CAVC,
hypoplastic arch
Repair AVV for residual AVVR 3 Died
11 HLHC, ALCAPA Revision of ALCAPA button 2 DC
12 HLHS Clot extraction from proximal RCA 2 DC
All patients who underwent intraoperative surgical reinterventions to correct residual defects identified either on transesophageal or epicardial echocardiography or based on
clinical status after initial weaning from cardiopulmonary bypass. RACHS, Risk Adjustment in Congenital Heart Surgery; VSD, ventricular septal defect; DC, discharged;
RVOTO, right ventricular outflow tract obstruction; RVOT, right ventricular outflow tract; TOF, tetralogy of Fallot; APV, absent pulmonary valve; RPA, right pulmonary artery;
CAVC, complete atrioventricular canal; AVV, atrioventricular valve; AVVR, atrioventricular valve regurgitation; TGA, transposition of the great arteries; IVS, intact ventricular
septum; PA, pulmonary artery; RV, right ventricular; LAVV, left atrioventricular valve; ASD, atrial septal defect; LPA, left pulmonary artery;MAPCA, major aortopulmonary col-
lateral artery; HLHC, hypoplastic left heart complex; ALCAPA, anomalous left coronary arising from pulmonary artery; HLHS, hypoplastic left heart syndrome; RCA, right cor-
onary artery.
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a health care intervention and is associated with suboptimal outcome.’’11 A
major postoperative adverse event ‘‘is a complication that causes increased
consumption of resources (above and beyond average), or permanent
morbidity.’’11
The following postoperative major adverse events were included for
analysis: stroke or major neurologic deficit, need for extracorporeal mem-
brane oxygenation, cardiac arrest requiring cardiopulmonary resuscitation,
reoperation for bleeding or low cardiac output state, reoperation for resid-
ual defects, unexpected catheter-based reintervention, need for a permanent
pacemaker, mediastinitis requiring surgical debridement, diaphragmatic
paralysis requiring surgical plication, in-hospital mortality, or mortality
in less than 30 days if discharged (per The Society of Thoracic Surgeons
database criteria).
Statistical Methods
Categorical variables are summarized as numbers and percentages, and
continuous variables are summarized as means  standard deviation with
(medians and range). Patient characteristics for those with and without ma-
jor postoperative adverse events were compared using the c2 test for cate-
gorical variables and the Mann-Whitney test and Kruskal-Wallis test for
continuous variables. Variables significant at the .05 level were considered
for inclusion in a multivariable logistic regression model. Forward selec-
tion was used to fit the model. For coding ‘‘technical performance,’’ opti-
mal technical performance was used as reference. For coding the
‘‘RACHS-1 categories,’’ RACHS-1 category 2 was used as the reference.
Discrimination of these factors for predicting a major postoperative ad-
verse event was assessed using the receiver operator characteristic curve
(Figure 1).
Relationships between continuous outcomes variables and continuous
patient characteristics were evaluated using the Spearman rank correlation
coefficient. For categorical characteristics, median values of the outcomes
were compared using the Mann-Whitney test for variables with 2 cate-
gories and the Kruskal-Wallis test for variables with 3 or more categories.
A subgroup analysis was performed comparing patients who had intra-
operative surgical reinterventions, patients who had postoperative surgical
or catheter-based reinterventions, and those requiring no reinterventions.
IBM SPSS Statistics 18 for Window (SPSS, Inc, Chicago, Ill) was used
for statistical analysis.1100 The Journal of Thoracic and Cardiovascular SurRESULTS
A total of 166 patients were prospectively observed and
all were included in the analysis.
There were 94 (57%) male patients. The mean age was
49.1  49.4 days (range, 0-156 days). Mean weight was
3.9  1.2 kg (range, 1.7-7.2 kg). Thirteen (8%) weighed
less than 2.5 kg. Neonates accounted for 50% (n ¼ 83).
There were 10 premature infants (<35 weeks). Twenty-
nine (17%) had defined chromosomal abnormalities and
15 (9%) had extracardiac abnormalities.
Eighty-four (51%) were RACHS 2 and 3 (categorized as
low risk) and 82 (49%) were RACHS 4, 5, and 6 (catego-
rized as high risk). Diagnoses and procedures performed
are represented in Tables E1 and E2.
For the entire cohort, preoperative PRISM III score was
6.3  4.3 (mean and range, 6, 0-21), Preoperative lactate
level was 1.6  1.3 (1, 0.6-13.2), CPB time was 140  59
(132, 38-379), aortic crossclamp time was 77  38
(75, 0-194), deep hypothermic circulatory arrest time was
22  19 (12, 1-75) (n ¼ 57), and regional low-flow perfu-
sion time was 48 18 (46, 5-86) (n¼ 46). PRISM III score
on postoperative day 1 was 11.3  6.4 (10, 0-34), and lac-
tate level on postoperative day 1 was 5.7  5.2 (3.8, 0-28).
Postoperative hospital length of stay was 26  32 (15,
1-191), postoperative ICU length of stay was 15.4  24
(8, 1-188), and postoperative ventilator time (in days) was
10  20 (4, 1-188).
Intraoperative revisions requiring reinstitution of CPB
(n ¼ 12, 7%), unexpected postoperative surgical reinterven-
tions (n ¼ 14, 11 patients, 8%) and postoperative catheter-
based reinterventions (n ¼ 22, 19 patients, 11%) are
represented inTables 1, 2, and3.TableE3depicts all intraoper-
ative adverse events that were documented. Table E4 depictsgery c November 2011
TABLE 2. Postoperative surgical reinterventions (n ¼ 14; 11 patients; 8%)
No. RACHS Diagnosis
Postop surgical
intervention
Postop cath
intervention
Intraop
revision
Assigned tech
score
Tech score based
on DC echo Outcome
1 3 TOF/right-
dominant
CAVC, PAPVR
Repair of recurrent
MR from torn
cleft sutures
No No 3 2 DC home
2 3 HLHC: BDG, TV
plasty, aortic
valve plasty, TD
of RV-PA
conduit
1. TV replacement
2. Repair
paravalvar leak
and
reconnection of
RV-PA conduit
(PPM for CHB)
No No 3 3 Died
3 4 Truncus
arteriosus
Revision of RV-PA
conduit, partial
closure of ASD
BD of RV-PA
conduit and
LLPA, LLPA
stent
No 3 3 (RVP still
2/3 systemic
after BD)
Died
4 4 TOF, PA,
MAPCAs
Revision of
unifocalized
RPA, banding
of RV-PA
conduit
BD of RPA,
RLLPA, LPA
stent
No 3 2 DC home
5 4 TGA/VSD Closure of
residual ASD
LPA stenting No 3 2 DC
6 4 HLHC- CoA,
VSD, small left-
sided structures
1. Reimplantation
of torn AL
papillary
muscle
2. MV
replacement
(PPM for CHB)
No No 3 3 Transplanted
7 5 Neonatal Ebstein RV-PA conduit,
TV repair and
repositioning
RVOT stenting No 3 2 Died
8 6 Shone, IAS Early BDG and
LPA plasty
MV BD in attempt
to delay BDG
No 2 1 DC
9 6 UnbCAVC s/p
stage I, Sano,
AVV septation
for AVVR
1. AVV repair
2. AVV repair
No No 3 3 Died
10 6 HLHS, ALCAPA Conversion of
BTS to RV-PA
conduit
No Revised
ALCAPA
button)
3 2 DC
11 6 d-TGA, VSD,
hypoplastic RV,
straddling TV
TV and MV repair
(PPM for CHB)
BD of innominate
vein, coiling
VV collaterals
No 3 3 DC
All patients who underwent postoperative surgical reintervention for residual defects. Note that there is higher proportion of patients in the higher RACHS-1 categories. RACHS,
Risk Adjustment in Congenital Heart Surgery; cath, catheter;DC, discharge; TOF, tetralogy of Fallot; CAVC, complete atrioventricular canal; PAPVR, partial anomalous pulmonary
venous return;MR,mitral regurgitation;HLHC, hypoplastic left heart complex;BDG,bidirectional Glenn;TV, tricuspid valve;TD, takedown;RV-PA, right ventricle–pulmonary artery;
PPM, permanent pacemaker;CHB, complete heart block; ASD, atrial septal defect; BD, balloon dilation; LLPA, left lower pulmonary artery; RVP, right ventricular pressure; PA, pul-
monaryatresia;MAPCA,major aortopulmonarycollateral artery;RPA, rightpulmonary artery;RLLPA, right lower left pulmonary artery;LPA, left pulmonary artery;TGA, transposition
of the great arteries; VSD, ventricular septal defect; CoA, coarctation of the aorta; AL, anterolateral; RVOT, right ventricular outflow tract; IAS, intra-aortic septum;MV,mitral valve;
UnbCAVC, unbalanced complete atrioventricular canal; s/p, status post;AVV, atrioventricular valve;AVVR, atrioventricular valve regurgitation;HLHS, hypoplastic left heart syndrome;
ALCAPA, anomalous left coronary arising from pulmonary artery; d-TGA, dextro-transposition of the great arteries; RV, right ventricle; VV, venovenous.
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catheter-based reinterventions based on RACHS-1 categories.
Major postoperative adverse events occurred in 47 (28%)
and are represented in Table E5. Thirteen (8%) requiredThe Journal of Thoracic and CarECMO (1 preoperative only, 1 preoperative and postopera-
tive, 11 postoperative).
There were 7 (4.2%) deaths of which 5 occurred in neo-
nates (Table E6). Inasmuch as the number of deaths wasdiovascular Surgery c Volume 142, Number 5 1101
TABLE 3. Postoperative catheter interventions (n ¼ 22; 19 patients, 11%)
No. RACHS Diagnosis
Postop cath
interventions
Postop surgical
intervention
Intraop
revision
Assigned tech
score
Tech score based
on DC echo Outcome
1 3 TOF, APV BD of LUPV No Revision of RPA
anastomosis
2 2 DC
2 3 LCA occlusion
and RV-PA
conduit regurg
s/p neonatal
Ross Konno
BD of RPA
stenosis
No No 3 3 DC (required
OHT)
3 3 TOF, CAVC ASD creation for
PHTN
No No 3 3 (severe PR) DC (late death)
4 3 TA/PA,
TGAVSD,
s/p BTS
BD of BTS
insertion and
branch pulm
arteries
No No 3 3 (2nd cath 1 mo
later to redialte
BTS and branch
pulm arteries
DC
5 4 Truncus
arteriosus,
discontinuous
RPA
BD of RPA and
coil APC
No No 3 2 DC
6 4 Truncus
arteriosus
BD of RV-PA
conduit and
LLPA, LLPA
stent
Revision of RV-PA
conduit, partial
closure of ASD
No 3 3 (RVP still 2/3
systemic after
BD)
Died
7 4 TOF, MAPCAs BD of RPA and
LPA, APC
coiling
No Fenestration of
VSD
3 3 DC
8 4 TOF, PA,
MAPCAs
BD of RPA,
RLLPA, LPA
stent
Revision of
unifocalized
RPA, banding
of RV-PA
conduit
No 3 2 DC
9 4 TOF, PA,
MAPCAs,
premie 34 wk,
SGA
1. Bilateral pulm
artery dilatation
and stenting
2. Bilateral stented
pulm artery
dilatation
No No 3 3 DC, late death
10 4 d-TGA, PS,
hypoplastic RV
BD of both
bilateral pulm
arteries, APC
coiling
No No 3 2 DC
11 4 TGA/VSD LPA stenting Closure of residual
ASD
No 3 2 DC
12 4 TGA, VSD, arch
hypoplasia
ASD dilatation
and LPA
stenting
No No 3 2 DC
13 4 TGA, VSD, arch
hypoplasia
BD of RCA No No 3 2 DC
14 5 Neonatal Ebstein RVOT stenting RV-PA conduit
and TV
repositioning
and repair
No 3 2 Died
15 6 Shone, IAS MV BD in
attempt to
delay BDG
Early BDG and
LPA plasty
No 2 1 DC
16 6 No No 3 1 DC
(Continued)
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TABLE 3. Continued
No. RACHS Diagnosis
Postop cath
interventions
Postop surgical
intervention
Intraop
revision
Assigned tech
score
Tech score based
on DC echo Outcome
HLHC, s/p
stage I BTS
BD and stenting of
distal BTS and
ASD dilatation
17 6 Heterotaxy, aortic
arch hypoplasia,
TAPVR s/p
DKS, arch
augmentation,
TAPVR repair
1. BD of pulm
veins
2. BD of pulm
veins
No No 3 3 DC
18 6 HLHS, ALCAPA 1. Cath to stent
LCA and BD of
RPA
2. Stent distal RV-
PA conduit
No No 3 3 Died
19 6 d-TGA, VSD,
hypoplastic RV,
straddling TV
BD of innominate
vein, coiling of
APC, TV and
MV repair
(PPM for CHB)
TV and MV
repair (PPM for
CHB)
No 3 3 DC
All patients who underwent postoperative catheter-based reinterventions for residual defects. Note that there is a higher preponderance of patients in the higher RACHS-1 cat-
egories.RACHS,Risk Adjustment in Congenital Heart Surgery; cath, catheter;DC, discharge; TOF, tetralogy of Fallot; APV, absent pulmonary valve;BD, balloon dilation; LUPV,
left upper pulmonary vein; RPA, right pulmonary artery; LCA, left coronary artery; RV-PA, right ventricle–pulmonary artery; s/p, status post; OHT, orthotopic heart transplant;
CAVC, complete atrioventricular canal; ASD, atrial septal defect; PHTN, pulmonary hypertension; PR, pulmonary regurgitation; TA, tricuspid atresia; PA, pulmonary atresia;
TGA, transposition of the great arteries; VSD, ventricular septal defect; BTS, Blalock-Taussig shunt; APC, aortopulmonary collateral artery; LLPA, left lower pulmonary artery;
RVP, right ventricular pressure;MAPCA,major aortopulmonary collateral artery; LPA, left pulmonary artery;RLLPA, right lower left pulmonary artery; SGA, small for gestational
age; d-TGA, dextro-transposition of the great arteries; PS, pulmonary stenosis; RV, right ventricle; RCA, right coronary artery; TV, tricuspid valve; RVOT, right ventricular outflow
tract; IAS, intra-aortic septum; BDG, bidirectional Glenn;HLHC, hypoplastic left heart complex; TAPVR, total anomalous pulmonary venous return;DKS,Damus-Kaye-Stansel;
HLHS, hypoplastic left heart syndrome; ALCAPA, anomalous left coronary arising from pulmonary artery;MV, mitral valve; PPM, permanent pacemaker; CHB, complete heart
block.
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measure did not have enough power to correctly detect sig-
nificance; therefore it was included as a component of major
postoperative adverse event.
Major postoperative adverse events and postoperative
ventilation times, as well as postoperative length of ICU
and hospital stay, were the major and minor outcomes in-
cluded in our analysis.
There was no significant difference in the rate of postop-
erative major adverse events or the rates of intraoperative or
postoperative surgical or catheter-based reinterventions be-
tween surgeons.
On univariate analysis, higher RACHS-1 scores were as-
sociated with higher occurrence of major postoperative ad-
verse events (P < .0001), with longer ventilation days
(P< .0001), longer ICU lengths of stay (P< .0001), and
higher hospital lengths of stay (P< .0001). Younger age
(P< .001) and lower weight (P< .003) were associated
with higher occurrence of major postoperative adverse
events (P<.003), and both were associated with higher ven-
tilation days and postoperative ICU and hospital lengths of
stay (P<.0001). There was no significant difference for oc-
currence of major postoperative adverse events by prematu-
rity (P ¼ .547), by presence of extracardiac or geneticThe Journal of Thoracic and Carabnormalities (P ¼ .098), or by need for intraoperative sur-
gical reintervention (P ¼ .689). However, the presence of
extracardiac or genetic abnormalities was associated with
longer ventilation days and postoperative ICU and hospital
lengths of stay (P<.01, P<.001, P<.002, respectively),
whereas this was not significant in premature infants
(P¼ .745,P¼ .231,P¼ .437, respectively). Longer median
CPB times and aortic crossclamp timeswere associated with
significantly longer ventilation times (P, .0001 and P<.005,
respectively), longer postoperative ICU lengths of stay
(P<.000 and P<.024, respectively), and longer postoper-
ative hospital lengths of stay (P<.0001 andP<.047, respec-
tively). The results of univariate analysis are included in
Table 4. Bivariate association was used to choose variables
withP<.05 for inclusion in logistic regression. Of note, pre-
maturity, weight, neonates, and intraoperative adverse
events (which included intraoperative surgical reinterven-
tions), aortic crossclamp time, and preoperative lactate
level, were found to be nonsignificant on logistic regression.
Technical performance score, RACHS category, and
preoperative PRISM in combination performed best in the
logistic regression analysis (Figures 1 and 2). Technical
performance score, RACHS, and CPB times in
combinationwere also significant, but slightly less powerful.diovascular Surgery c Volume 142, Number 5 1103
TABLE 4. Univariate analysis
Major postoperative adverse events
Variables No (n ¼ 119) Yes (n ¼ 47) P value
Low birth weight (<2.5 kg) 4.2% 17% .006
Prematurity 6.7% 4.3% .547
Gender ¼ female 46.2% 36.2% .239
Extracardiac anomaly 6.7% 14.9% .098
Genetic anomaly 20.2% 10.6% .145
Intraop adverse event 28.6% 57.4% .001
Intraop surgical
reintervention
6.7% 8.5% .689
RACHS high risk 37.8% 78.7% .000
Technical performance
Optimal 42% 19.1% .000
Adequate 56.3% 23.4% .000
Inadequate 1.7% 57.4% .000
Neonate 39.5% 76.6% .000
Weight 3.9 3.4 .003
CPB time 123 176 .000
Aortic crossclamp time 72 81 .047
Hypothermic arrest (if
applicable)
9 16 .392
Regional perfusion (if
applicable)
42 48 .290
Ventilation (d) 3 13 .000
Postop ICU length of stay 5 23 .000
Postop hospital length of stay 11 44 .000
Preop PRISM 6 9 .000
Preop lactate 1 1.7 .000
Postop day 1 PRISM 8 16 .000
Postop day 1 lactate 2.6 8.6 .000
Categorical variables are represented as percentages and continuous variables are
represented as medians. RACHS, Risk Adjustment in Congenital Heart Surgery;
CPB, cardiopulmonary bypass; ICU, intensive care unit; PRISM, Pediatric Risk of
Mortality.
FIGURE 2. Major postoperative adverse events based on technical scores
and RACHS-1 categories. This figure outlines the percentage of patients
with major postoperative adverse events comparing technical performance
and RACHS-1 risk categories. Optimal technical performance had a low
occurrence of adverse events, whereas adequate technical performance
had low rates of adverse events in the low complexity groups (RACHS-1
categories 2 and 3, but higher percentage of adverse events in the higher
risk categories (RACHS-1 categories 4 and 6). Inadequate technical perfor-
mance had the highest percentage with adverse events in all categories of
the RACHS-1 system. RACHS, Risk Adjustment in Congenital Heart
Surgery.
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who had intraoperative surgical revisions with the group
that required postoperative surgical or catheter-based inter-
ventions. There was a significant difference in the discharge
technical score of those who had intraoperative interven-
tions versus those who required postoperative surgical or
catheter-based reinterventions (P<.0001). On comparing
duration of ventilation and ICU and hospital lengths of
stay, there was again a significant difference (P< .001,
P<.001, P<.005, respectively) (Figure 3, Figure E1). Mor-
tality and occurrence of major postoperative adverse events
was also significantly different (Figure E2).DISCUSSION
This study demonstrates that, across a broad spectrum of
complex neonatal and infant cardiac repairs, technical per-
formance score had the strongest association with out-
comes. In addition, it points to what can be called
a ‘‘technical imperative,’’ an absolute rule whereby it is
‘‘imperative’’ to leave the operating room with a good or1104 The Journal of Thoracic and Cardiovascular Surbetter yet optimal technical result, even if this requires sur-
gical revision. Indeed, the patients who required intraoper-
ative revisions did not do significantly worse than the
patients who had no intraoperative and no postoperative re-
interventions. On the other hand, failure to detect and inter-
vene on intraoperative findings of inadequate technical
result led to delayed intervention, either surgical or
catheter-based, with its resultant increase in occurrence of
postoperative adverse events, prolonged lengths of stay
and ventilation time, as well as mortality.
It is obvious that surgical outcomes are not solely depen-
dent on the technical prowess of the surgeon. This study
also showed that the RACHS-1 score, a risk stratification
paradigm currently most used by insurance companies, per-
formed almost as well as the technical score in predicting
outcomes, followed closely by the preoperative PRISM
score, an index of physiologic illness severity. Whereas
the RACHS-1 class is a fixed value that cannot be modified,
the physiologic status of an infant can often be improved by
medical means before surgical repair. This therefore also
vindicates another surgical dogma, namely, to not operate
on an infant if there is a possibility of improving the infant’s
physiologic status.12
This study is a single-center study and looks at cases by 6
surgeons of vastly different experience levels.We did not re-
strict ourselves to a single procedure or diagnosis. Thus, thisgery c November 2011
FIGURE 3. Postoperative ICU LOS for intraoperative surgical reinter-
ventions versus postoperative surgical reinterventions or catheter-based re-
interventions when compared with those who had no intervention: The was
no statistical difference in the median LOS for patients who had no reinter-
ventions (6 days) versus patients with intraoperative reinterventions (13
days) (P ¼ .141). However, patients who had postoperative surgical or
catheter-based reinterventions had a significantly longer LOS (32 days)
(P ¼ .005 vs intraoperative reinterventions, P<.0001 vs no reinterven-
tions). *Outliers. ICU, Intensive care unit; LOS, length of stay.
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snapshot as possible from a large pediatric heart center. Fur-
thermore, all observers were trained pediatric cardiac sur-
geons, increasing the quality of the observed intraoperative
data, and minimizing the likelihood of missing an important
event. Previous work from our institution had shown the im-
portance of technical performance in outcomes, specifically
for the Norwood stage I procedure where it had a direct im-
pact on hospital survival. Optimal technical performance
also attenuated the effects of case complexity and physio-
logic severity of illness.1A similar effect (postoperativemor-
bidity escalated by worse physiologic status, but attenuated
by improved surgical technique) was also shown for another
high-risk surgical procedure, namely, pancreatic resection,
in a prospective study of 412 patients.13
For ‘‘routine’’ cases of complete atrioventricular canal,
tetralogy of Fallot, and ventricular septal defect repairs, as
well as arterial switches, in part owing to the very low mor-
tality seen with these procedures, the impact of technical
scores on mortality was not as dramatic. Many researchers
have therefore switched to indices of morbidity,14 such as
the occurrence of major postoperative events as used in
the present study. The study’s focus on complex infant re-
pairs further improved our ‘‘yield.’’ In accordance with
many other studies, we found that a substantial number of
infants have significant adverse events during the postoper-
ative period.15,16 Defining and addressing the factors that
contribute to those is a logical way to improve patient
outcomes and also decrease health care cost.The Journal of Thoracic and CarPediatric cardiac surgery outcomes often depend on the
function of fragile microstructures. Thus, it is not surprising
that a certain number of patients require intraoperative revi-
sion. This study is the first to compare patients who under-
went intraoperative revisions with those who required
postoperative interventions. The results are unequivocal
and show that it is the end result that counts. Technical com-
pensation was able to neutralize the deleterious effects of
having to go back on CPB a second time. CPB time came
in as a close fourth behind technical scores, RACHS-1,
and PRISM III scores for inclusion in the logistic regression
analysis. Longer time was significantly associated with
a higher incidence of major postoperative adverse events,
a finding that is not surprising given the known deleterious
effects of prolonged CPB times, especially in neonates.
However, we do not think that there is a proven cause and
effect relationship in this respect, and our study supports
the fact that technical outcome is by far more important
than shortening CPB time.
Study limitations include the fact that this is a single-
center study, with results that may not be generalizable to
other centers. The numbers in each risk category are rela-
tively small, inasmuch as a wide range of diagnoses was in-
cluded. The PRISM score has not been validated for
cyanotic heart disease, but there is currently no accepted
way to measure preoperative illness severity.
In conclusion, this prospective study involving 166 com-
plex neonatal and infant cardiac repairs shows that optimal
technical performance scores result in best outcomes, even
if an intraoperative revision has to be performed, and atten-
uates the effects of poor preoperative physiology across
a wide spectrum of diagnoses and procedures.References
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Dr Marc R. de Leval (London, United Kingdom). I congratu-
late Dr Nathan for this very clear presentation. This work is an ad-
dition to the already impressive list of contributions of Dr Bacha
and colleagues to outcome analysis, risk management, and patient
safety research. In a previous study, they had introduced the con-
cept of technical performance asmeasured by technical scores spe-
cific to each operation. The technical scores are graded as optimal,
adequate, and inadequate.
In this study, they have undertaken a prospective analysis of the
impact of technical performance on outcomes for the whole spec-
trum of congenital heart defects in infants in a single institution,
the operations being performed by 6 different surgeons at various
stages of their training and experience. The RACHS scoring sys-
tem was used for the case complexity and the PRISM scoring sys-
tem was used to score the preoperative and postoperative
physiologic status.
The findings were as follows:
1. Technical performance is the single most important determi-
nant of outcomes.
2. Optimal technical performance mitigates the effects of case
complexity and physiologic severity of the illness.
3. Optimal technical performance leads to good outcomes even if
an intraoperative revision is required. The technical compensa-
tion neutralizes the deleterious effects of having to go back on
CPB a second time.
4. Intraoperative revisions lead to better results than postoperative
interventions.
5. The physiologic status of the patient can often be improved by
medical means before surgery and this improves the overall re-
sults.
I have 1 comment and 3 questions. I find the term ‘‘technical
performance’’ somewhat misleading. It gives the impression that
it relates essentially to surgical dexterity. I personally believe
that going back on CPB and revising successfully a complex repair1106 The Journal of Thoracic and Cardiovascular Surin a sick infant requires as much cognitive skills as technical skills.
There is some analogy within sports psychology where studies of
physical, technical, and mental skills show that the only predictor
of final Olympic achievements, the difference between gold and
silver medalists, was the mental readiness, which is made of com-
mitment, confidence, and positive thinking. What you have actu-
ally analyzed is the quality of the repair rather than technical
performance. What do you think about this comment? This is
my first question.
The aviation industry has introduced crew resource manage-
ment training to manage adverse events. Do you think this could
be applicable to surgery by the so-called nontechnical skills tech-
nique training, and do you think that this could be introduced in the
curriculum of medical schools and residency programs? This is my
second question.
The operations were performed by 6 surgeons. Was there a dif-
ference in the outcomes of those 6 surgeons?
My last point is a minor point. You do not discuss in the manu-
script what kind of investigations were done intraoperatively to as-
sess the quality of the repair. I assume that assessments were made
by transesophageal echocardiogram. I wonder whether the reinter-
vention rate intraoperatively could be increased by refining the in-
traoperative assessment of your repair, thus reducing the need for
postoperative interventions.
Dr Nathan. Thank you, Dr de Leval, for your questions. I agree
that the term ‘‘technical performance’’ seems to implicate the sur-
geons, whereas outcomes in surgery for congenital cardiac disease
are not only dependent on the way the surgery is performed but on
several of other factors, including the postoperative course and
ICU care. We have therefore decided to refine our statement and
call this technical performance scores rather than just technical
performance.
I agree that the airline industry has excellent simulation pro-
grams, and I think there are several centers beginning simulation
programs, including our center, for management of events in the
operating room.
There were 6 surgeons involved in this study, and there was no
significant difference among the technical performance scores of
these surgeons.
We did use intraoperative transesophageal echocardiography
for the bigger babies, and if the babies were really small, we
used epicardial echocardiography. We are in the process of defin-
ing criteria for each of these methods of investigation and are also
developing a technical performance score for intraoperative
assessment.
DrMuhammadMumtaz (Norfolk, Va). I have 2 questions. Do
I understand from your conclusions that if the outcome in the op-
erating room is less than optimal, revising the result to make it the
ideal outcome does not affect any adverse events? That is to say, if
one goes back on for a second pump run on the pump and revises,
whether it was a residual ventricular septal defect or whatever,
then it does not affect how the baby is going to do? Do I understand
that correctly?
Dr Nathan. Yes, you do.
Dr Mumtaz. It sounds a little bit odd. I would just intuitively
disagree with that.
Second, I want to focus on the premature babies. There are 10
noted in your series, and you said you defined them by less thangery c November 2011
Nathan et al Congenital Heart Disease35 weeks at birth. At what age were these babies offered sur-
gery? Were these offered surgery at less than 35 weeks of cor-
rected age or were they offered surgery at a different corrected
age?
Dr Nathan. The majority of them are operated on in the first
week of life; unless their diagnosis warranted surgery at 2 to 3
months, as is the case with tetralogy of Fallot and complete atrio-
ventricular canal defects, which are operated on a few weeks later.The Journal of Thoracic and Car
DDr Mumtaz. So at your institution, the protocol for premature
babies does not consider the corrected age? Do I understand that
correctly?
Dr Nathan. It depends on the complexity of the case and need
for intervention.We did not use prematurity as an indicator to post-
pone surgery for any length of time if the case was complex and
needed immediate surgery.
Dr Mumtaz. Thank you.diovascular Surgery c Volume 142, Number 5 1107
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FIGURE E1. Comparison of occurrence of major adverse events for no
intervention versus intraoperative intervention versus postoperative surgi-
cal or catheter-based interventions. There was significantly higher inci-
dence of major postoperative adverse events in the postoperative
surgical/catheter reinterventions group (P < .0001 vs no intervention,
P ¼ .007 intraoperative surgical reinterventions).
FIGURE E2. Comparison of mortality for no intervention versus intrao-
perative intervention versus postoperative surgical or catheter-based inter-
ventions. There is a significantly higher mortality for patients who
underwent postoperative surgical/catheter reinterventions when compared
with those who had no reintervention (P<.0001).
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TABLE E1. List of diagnoses in 166 patients
VSD ¼ 15 Truncus arteriosus¼ 6 DORV ¼ 3
TOF/PS ¼ 19 AP window ¼ 2 DOLV ¼ 1
TOF/PA/single
ductlike
collateral ¼ 2
TGA/IVS ¼ 7 Malposed atrial
septum ¼ 1
TOF/PA/
MAPCAs ¼ 6
TGA/VSD ¼ 9 LV-aorta tunnel ¼ 1
TOF/APV ¼ 2 Tricuspid atresia ¼ 4 AS/AR ¼ 5
TOF/CAVC ¼ 4 HLHS ¼ 24 MR ¼ 1
CAVC ¼ 13 HLHC ¼ 9 PA/IVS ¼ 2
Transitional AVC ¼ 2 Neonatal TAPVR ¼ 4 Supra AS/PS ¼ 1
CoA, arch
hypoplasia ¼ 1
UCAVC ¼ 4 Neonatal Ebstein ¼ 1
IAA ¼ 3 DILV ¼ 1
CoA/VSD ¼ 5 Heterotaxy/
UnbCAVC/
TAPVR, etc ¼ 8
VSD, Ventricular septal defect; TOF, tetralogy of Fallot; PS, pulmonary stenosis; PA,
pulmonary atresia; MAPCA, major aortopulmonary collateral artery; APV, anoma-
lous pulmonary vein; CAVC, complete atrioventricular canal; AVC, atrioventricular
connection; CoA, coarctation of the aorta; IAA, interrupted aortic arch; AP, aortopul-
monary; TGA, transposition of the great arteries; IVS, interventricular septum;
HLHS, hypoplastic left heart syndrome; HLHC, hypoplastic left heart complex;
TAPVR, total anomalous pulmonary venous return; UCAVC, unbalanced complete
atrio-ventricular canal; DILV, double-inlet left ventricle; UnbCAVC, unbalanced
complete atrioventricular canal; DORV, double-outlet right ventricle; DOLV,
double-outlet left ventricle; LV, left ventricle; AS, aortic stenosis; AR, aortic regur-
gitation; MR, mitral regurgitation.
TABLE E2. List of all procedures performed based on RACHS-1 categories (n ¼ 166)
RACHS 2 (n ¼ 40) TV repair ¼ 2 TOF/PA full repair with unifocalization ¼ 5
AP window repair ¼ 2 CAVC ¼ 13 IAA/VSD ¼ 2
Common atrial septation ¼ 1 RMBTS ¼ 2 Rastelli ¼ 3
TOF, TAP ¼ 2 TAPVR ¼ 1 Neonatal Ross Konno ¼ 2
TOF valve sparing ¼ 15 ASO ¼ 7 ASO/VSD ¼ 8 (with arch ¼ 5)
RVOT patch ¼ 1 Transitional AVC ¼ 1 Arch augmentation/pulmonar artery band ¼ 2
BDG ¼ 3 Aortic valve repair ¼ 2 Biventricular repair for Shone complex ¼ 2
Kawashima ¼ 1 Valve sparing root replacement ¼ 1 CoAþarch ¼ 1
VSD ¼ 15 Supra AS/PS repair ¼ 1 RACHS 5 (n ¼ 1)*
RACHS 3 (n ¼ 44) LV-aorta tunnel ¼ 1 Neonatal Ebstein’s repair ¼ 1
DORV/VSD baffle ¼ 2 RACHS 4 (n ¼ 47) RACHS 6 (n ¼ 34)
MV repair ¼ 2 Neonatal TAPVR ¼ 5 Norwood BTS ¼ 9
TOF/APVor pulmonary artery conduit ¼ 2 VSDþarch ¼ 6 Norwood Sano ¼ 21
Conduit change ¼ 2 Truncus arteriosus repair ¼ 6 DKS ¼ 4
TOF/CAVC ¼ 4 Comprehensive stage II ¼ 2
TOF supramitral ring ¼ 1 Unifocalization only ¼ 3
RACHS, Risk Adjustment in Congenital Heart Surgery; AP, aortopulmonary; TOF, tetralogy of Fallot; TAP, transannular patch; RVOT, right ventricular outflow tract; BDG, bi-
directional Glenn; VSD, ventricular septal defect;DORV, double-outlet right ventricle;MV,mitral valve;APV, absent pulmonary valve;CAVC, complete atrioventricular canal; TV,
tricuspid valve; RMBTS, Blalock-Taussig shunt; TAPVR, total anomalous pulmonary venous return; ASO, arterial switch operation; AVC, atrioventricular canal; AS, aortic ste-
nosis; PS, pulmonary stenosis; LV, left ventricle; IAA, interrupted aortic arch; CoA, coarctation of the aorta;DKS,Damus-Kaye-Stansel. *The single patient in RACHS-1 category
5 was included in category 6 for analysis.
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TABLE E3. Intraoperative adverse events patient (n ¼ 61; 37%)
Main problem area
Bleeding (17)
Bleeding intraoperatively ¼ 9 (cannula site, ductus arteriosus, descending thoracic aorta)
Reexploration for bleeding ¼ 7 (chest initially closed in 3)
Factor VII for uncontrolled ongoing bleeding ¼ 1
Perfusion/CPB
Venous line fell on floor during circulatory arrest ¼ 1
Air in oxygenator secondary to failure of low level indicator ¼ 1 (successfully picked up and purged—no patient adverse event)
Inadvertent drainage of patient during CPB wean (new machine) ¼ 1
Manifold leak in circuit requiring change ¼ 1
High membrane pressure, high filling pressures on ECMO ¼ 1
Lower body malperfusion ¼ 1
Inadvertent venous decannulation ¼ 1
Air in venous line from failure to clamp ¼ 2
Air lock in venous line ¼ 1
Airway/pulmonary
Difficulty in ventilation from abnormal lung compliance ¼ 2
Difficult intubation ¼ 1
Arrhythmias
SVT requiring cardioversion ¼ 3
VT/VF requiring cardioversion ¼ 5
CHB/JR/EAT requiring pacing ¼ 16
SVT requiring urgent cannulation ¼1
Technical
Reinstitution of CPB for revision of residual defects ¼ 12
Inadvertent inclusion of left main in suture to control bleeding from RV-PA conduit (recognized and suture removed) ¼ 1
LPA dissection ¼ 1
Reinitiation of CPB to repair SVC cannulation ¼ 1
ST changes from air in coronary ¼ 1
ST changes after ALCAPA repair ¼ 2 (1 revised in operating room, 1 required LCA stent)
Pulmonary valve tear after BD requiring repair ¼ 3 (1 required conversion to TAP)
Miscellaneous
Cardiac arrest ¼ 5 (pre-CPB arrest ¼ 3, post-CPB arrest urgent cannulation ¼ 2)
Reinstitution of CPB for period of rest for LCOS, RV hypertension, hyperkalemia, air embolus, arrhythmia, LV distention ¼ 8
Hypotension during epicardial echo ¼ 1
Post-CPB arrest, CPR, cardioversion ¼ 2
Difficulty in CVL access ¼ 1
Chest reopened for LCOS, arrhythmia ¼ 5
ST changes in RVDCC requiring higher perfusion pressures ¼ 1
ECMO for inability to wean off CPB ¼ 3
Clipping of BTS for pulmonary overcirculation ¼ 1
Delay in arrival of blood products ¼ 1
Intraoperative adverse events: This includes events related to anesthesia, operative procedure, cardiopulmonary bypass, and events related to communication (some patients had
more than 1 event). CPB, Cardiopulmonary bypass; ECMO, extracorporeal membrane oxygenation; SVT, supraventricular tachycardia; VT, ventricular tachycardia; VF, ventric-
ular fibrillation; CHB, complete heart block; JR, junctional rhythm; EAT, ectopic atrial tachycardia; RV-PA, right ventricle–pulmonary artery; LPA, left pulmonary artery; SVC,
superior vena cava;ALCAPA, anomalous left coronary arising from pulmonary artery; LCA, left coronary artery; BD, balloon dilation; TAP, transannular patch; LCOS, low cardiac
output state; RV, right ventricle; LV, left ventricle; CPR, cardiopulmonary resuscitation; CVL, central venous line; RVDCC, right ventricle–dependent coronary circulation; BTS,
Blalock-Taussig shunt.
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TABLE E4. Rates of reinterventions based on RACHS-1 categories
RACHS-1
categories
Intraop
reinterventions
Postop
surgical
reinterventions
Postop
catheter-based
reinterventions
Median
ventilation
time (d)
Median
postop
ICU
LOS
(d)
Median
postop
hospital
LOS
(d)
Major
postop
adverse
events Mortality
RACHS-1 category 2
(n ¼ 40)
5% 0% 0% 1 3 6 2.5% 0%
RACHS-1 category 3
(n ¼ 44)
11.4% 4.6% 9.1% 3 6 12 20.5% 2.3%
RACHS-1 category 4
(n ¼ 47)
4.3% 10.6% 21.3% 7 11 21 38.3% 6.4%
RACHS-1 category 6
(n ¼ 35)
8.6% 11.4% 14.3% 10 17 29 54.3% 8.6%
Comparison of rates of intraoperative reinterventions and postoperative surgical or catheter-based reinterventions based on RACHS-1 categories. There were no RACHS-1 cat-
egory 1 patients in our study population. The single RACHS-1 category 5 patient was included with the RACHS-1 category 6 patients for analysis. RACHS, Risk Adjustment in
Congenital Heart Surgery; ICU, intensive care unit; LOS, length of stay.
TABLE E5. List of all major postoperative adverse events (n ¼ 47;
28%)
Neurologic ¼ 10
Subdural hemorrhage ¼ 1
Intraventricular hemorrhage ¼ 3
Cerebrovascular accidents ¼ 4
Seizures from small vessel emboli ¼ 2
Reexploration for bleeding ¼ 12
Reexploration for hemodynamic issues ¼ 16
Low cardiac output state ¼ 10
Restrictive right ventricular physiology ¼ 1
Hypoxia ¼ 1
Cardiac arrest ¼ 1
Blalock-Taussig shunt/Sano clipping ¼ 2
Removal of clip from shunt ¼ 1
Unbanding of right ventricle–pulmonary artery conduit ¼ 1
Cardiac arrest/unstable rhythm ¼ 3
Cardiopulmonary resuscitation ¼ 1
Cardioversion ¼1
Pericardiocentesis for tamponade ¼ 1
Postoperative extracorporeal membrane oxygenation ¼ 12
Postoperative surgical reinterventions for residual defects ¼ 12
Postoperative catheter reinterventions for residual defects ¼ 18
Complete heart block requiring intervention ¼ 5
Diaphragm plication ¼ 1
Sternal debridement ¼ 2
Miscellaneous ¼ 2
Fasciotomy for lower extremity ischemia ¼ 1
Exploration of retroperitoneal hematoma ¼ 1
Some patients had more than 1 event.
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TABLE E6. Mortality data (n ¼ 7; 4.2%)
Diagnosis (age)
RACHS-1
category
Technical
score Cath reintervention Surgical reintervention
1 HLHS, BDG, TV repair, aortic
valvotomy (100 d)
3 3 0 Reop-TVR
Reop-repair of paravalvular leak
2 TOF/PA/MAPCAs (96 d) 4 2 0 0
3 Truncus arteriosus (3 d) 4 3 BD of RV-PA conduit and LLPA Revision of RV-PA conduit and clot
extraction, ASD restriction
4 Neonatal Ebstein (1 d) 5 3 RVOT stenting Reop RV-PA conduit and TV repair
5 Heterotaxy, AA, CAVC, severe
AVVR (5 d)
6 3 0 Reoperation 3 2 to repair AVVR
6 UnbCAVC, arch hypoplasia,
AVVR (23 d)
6 3 0 0
7 HLHC, dysplastic MV,
ALCAPA (2 d)
6 3 2 (a) Stenting of LCA and RPA dilatation;
(b) RPA dilatation; stenting of RV-PA
conduit
0
This table lists all patients who died, the cause of mortality, and any intraoperative or postoperative reinterventions that were performed. RACHS, Risk Adjustment in Congenital
Heart Surgery; Cath, catheter; HLHS, hypoplastic left heart syndrome; BDG, bidirectinal Glenn; TV, tricuspid valve; TVR, tricuspid valve replacement; TOF, tetralogy of Fallot;
PA, pulmonary atresia; MAPCAs, major aortopulmonary collateral artery; BD, balloon dilation; RV-PA, right ventricle–pulmonary artery; LLPA, left lower pulmonary artery;
ASD, atrial septal defect; RVOT, right ventricular outflow tract; AA, aortic atresia; CAVC, complete atrioventricular canal; AVVR, atrioventricular valve regurgitation; UnbCAVC,
unbalanced complete atrioventricular canal;HLHC, hypoplastic left heart complex;MV,mitral valve; ALCAPA, anomalous left coronary arising from pulmonary artery; LCA, left
coronary artery; RPA, right pulmonary artery.
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